Researchers at Vanderbilt University Medical Center and their colleagues are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans.
A Vanderbilt University engineering professor has been selected to take part in the National Academy of Engineering’s 24th annual U.S. Frontiers of Engineering symposium Sept. 5-7 in Lexington, Mass.
A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.
For the second year, the School of Engineering’s biomechanics and assistive rehabilitation labs have received top honors for an event that introduces young students to a dynamic field that includes exoskeletons, sports and prosthetics.
Analysis of data from a clinical trial conducted at Vanderbilt suggests that deep brain stimulation (DBS) administered to patients with very early-stage Parkinson’s disease slowed the progression of rest tremor.
